Biochemical pharmacology

Wnt/β-catenin/ATF3 signaling may promote kidney damage from sudden injury to long-term disease by controlling removal of damaged mitochondria in mice

Updated

Abstract

Patients with kidney disease exhibited markedly elevated ATF3 levels compared with healthy controls.

  • Sustained activation of Wnt/β-catenin signaling may promote the progression from acute kidney injury (AKI) to chronic kidney disease (CKD).
  • Wnt1 overexpression in cell models disrupted mitochondrial structure and shifted dynamics toward fission while impairing mitophagy.
  • In vivo models showed similar mitochondrial changes, with KP6 treatment partially rescuing these defects.
  • ATF3 levels were found to correlate positively with serum creatinine, blood urea nitrogen, renal fibrosis, and glomerulosclerosis, and negatively with estimated glomerular filtration rate (eGFR).
  • Exogenous ATF3 impaired mitochondrial function, while silencing ATF3 preserved it, suggesting its role in mitochondrial dynamics.
  • ATF3 may serve as a potential biomarker for the progression from AKI to CKD.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free